- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
NHD, Concentra sign distribution agreement
National Healthcare Distributors (NHD) has signed a two-year contract with Concentra Managed Care of Boston. Under the contract, NHD will provide medical imaging supply distribution, service for film processors and x-ray equipment, and accessory products
National Healthcare Distributors (NHD) has signed a two-year contract with Concentra Managed Care of Boston. Under the contract, NHD will provide medical imaging supply distribution, service for film processors and x-ray equipment, and accessory products such as film and film filing supplies to Concentras 215 facilities across the U.S. NHD expects the contract to generate $2.5 million in business.
The deal is part of Beechwood, OH-based NHDs ongoing effort to forge alliances in the industry, and comes close on the heels of agreements signed with Eastman Kodaks Health Imaging division last September. Those agreements allow NHDs authorized Kodak distribution outlets to sell DryView laser imaging systems and name Kodak as NHDs primary source for x-ray processing chemicals (SCAN 9/29/99). NHD consists of 23 large imaging distributors, and was formed to procure some of the emerging national accounts business from large healthcare customers.
Can Innovations with AI Help Address the Impact of Staffing Shortages on Radiology Workflow?
October 7th 2024While staffing shortages in radiology continue to persist after the COVID-19 pandemic, current and emerging innovations powered by artificial intelligence (AI) may help facilities navigate these challenges and mitigate rising costs of health care.
AI Mammography Platform Shows Promising Results for Detecting Subclinical Breast Cancer
October 3rd 2024Mean artificial intelligence (AI) scoring for breasts developing cancer was double that of contralateral breasts at initial biennial screening and was 16 times higher at the third biennial screening, according to a study involving over 116,000 women with no prior history of breast cancer.
